Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001213900-20-000256
Filing Date
2020-01-06
Accepted
2020-01-06 16:19:25
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ff32020_aptorumgroup.htm F-3 683696
2 FORM OF INDENTURE WITH RESPECT TO SENIOR DEBT SECURITIES, TO BE ENTERED INTO BET ff32020ex4-6_aptorumgroup.htm EX-4.6 479096
3 FORM OF INDENTURE WITH RESPECT TO SUBORDINATED DEBT SECURITIES, TO BE ENTERED IN ff32020ex4-7_aptorumgroup.htm EX-4.7 306357
4 OPINION OF CAMPBELLS ff32020ex5-1_aptorumgroup.htm EX-5.1 55756
5 CONSENT OF MARCUM BERNSTEIN & PINCHUK LLP ff32020ex23-1_aptorumgroup.htm EX-23.1 3369
6 GRAPHIC ex23-1_001.jpg GRAPHIC 14630
7 GRAPHIC ex23-1_002.jpg GRAPHIC 5800
  Complete submission text file 0001213900-20-000256.txt   1557735
Mailing Address 17/F, GUANGDONG INVESTMENT TOWER 148 CONNAUGHT ROAD CENTRAL HONG KONG F4 999077
Business Address 17/F, GUANGDONG INVESTMENT TOWER 148 CONNAUGHT ROAD CENTRAL HONG KONG F4 999077 852 2117 6611
Aptorum Group Ltd (Filer) CIK: 0001734005 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-235819 | Film No.: 20509950
SIC: 2834 Pharmaceutical Preparations